Jeffrey B Rosen Selected Research

Coronary Disease (Coronary Heart Disease)

9/2015	Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.
7/2013	Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey B Rosen Research Topics

Disease

9	Shock 01/2019 - 09/2004
3	AIDS-Related Complex (ARC) 01/2019 - 01/2018
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 12/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 06/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 06/2009
2	Wounds and Injuries (Trauma) 01/2017 - 10/2013
2	Abdominal Obesity 09/2015 - 07/2013
2	Coronary Disease (Coronary Heart Disease) 09/2015 - 07/2013
2	Hypercholesterolemia 09/2015 - 06/2009
2	Insulin Resistance 09/2015 - 07/2013
1	Medically Unexplained Symptoms 01/2017
1	Obesity 07/2013
1	Anxiety Disorders (Anxiety Disorder) 12/2010
1	Hypersensitivity (Allergy) 06/2009
1	Hepatitis 06/2009
1	Exanthema (Rash) 06/2009
1	Depressive Disorder (Melancholia) 12/2005

Drug/Important Bio-Agent (IBA)

5	Ezetimibe (Zetia)FDA Link 09/2015 - 06/2009
5	Simvastatin (Zocor)FDA LinkGeneric 09/2015 - 06/2009
5	Atorvastatin (Lipitor)FDA Link 09/2015 - 06/2009
4	LipidsIBA 09/2015 - 06/2009
3	LDL CholesterolIBA 07/2013 - 05/2013
3	oxidized low density lipoproteinIBA 07/2013 - 05/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 01/2019
2	1,2- dihexadecyl- sn- glycero- 3- phosphocholineIBA 01/2019 - 01/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 10/2013
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2016 - 12/2010
2	ApolipoproteinsIBA 09/2015 - 07/2013
2	C-Reactive ProteinIBA 09/2015 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 07/2013
2	HDL CholesterolIBA 09/2015 - 07/2013
2	Triglycerides (Triacylglycerol)IBA 09/2015 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013 - 05/2013
2	CholesterolIBA 07/2013 - 07/2013
2	Rosuvastatin Calcium (Crestor)FDA Link 07/2013 - 05/2013
1	Biological ProductsIBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2016
1	antalarminIBA 01/2016
1	Messenger RNA (mRNA)IBA 11/2013
1	Apolipoproteins B (ApoB)IBA 07/2013
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2013
1	VLDL CholesterolIBA 07/2013
1	S 10 (S-10)IBA 05/2013
1	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 05/2013
1	N-Methylaspartate (NMDA)IBA 08/2009
1	Ibotenic AcidIBA 08/2009
1	GlucocorticoidsIBA 12/2005
1	Mifepristone (RU 486)FDA Link 11/2005
1	Proteins (Proteins, Gene)FDA Link 09/2004

Therapy/Procedure

2	Therapeutics 07/2013 - 06/2009
1	Aftercare (After-Treatment) 09/2015
1	Drug Therapy (Chemotherapy) 09/2015